LDL Cholesterol and Cardiovascular Disease: The Causal Link
LDL cholesterol (LDL-C) is a primary causal driver of atherosclerotic cardiovascular disease (ASCVD).
Pathophysiology
- Elevated LDL-C → increased subendothelial retention of apoB-containing lipoproteins
- Oxidation/modification → pro-inflammatory response
- Monocyte recruitment → foam cell formation → fatty streak
- Fibrous cap formation → atherosclerotic plaque
- Plaque rupture/erosion → thrombosis → MI, stroke, limb ischemia
Evidence
- Genetic (PCSK9, LDL-R variants): lifelong low LDL → markedly reduced CVD
- Mendelian randomization: confirms causality
- RCTs (statins, ezetimibe, PCSK9i): LDL lowering → proportional CVD risk reduction
Targets (ACC/AHA / ESC)
- Very high risk: <55 mg/dL (<1.4 mmol/L) and ≥50% reduction
- High risk: <70 mg/dL (<1.8 mmol/L)
- Primary prevention: risk-based (ASCVD score)
Therapeutic lifestyle + statin ± ezetimibe/PCSK9i/bempedoic acid achieves goals.
Cardiovascular Disease - Related Articles
- Understanding Coronary Artery Disease: Causes, Risk Factors & Outcomes
- Why Arterial Blood Is Bright Red: The Role of Oxyhemoglobin
- Low-Dose Aspirin and Heart Attack Prevention: Risks & Benefits
- Cardiac Risk Detection in Professional Athletes: Early Screening & Prevention
- Understanding Beta Blockers: Types, Uses & How They Work
- Understanding Varicose Veins: Causes, Symptoms & Treatment
- Foods to Boost HDL Cholesterol: A Comprehensive Guide
